Tumor virus infections happen when certain viruses infect your body and cause tumors or growths. These viruses are called oncogenic viruses, meaning they can turn normal cells into cancer cells. Think of it like a virus causing a problem that might lead to cancer over time.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Tumor virus infections are infections with viruses that can cause cancer or make it more likely. It is an umbrella term rather than one disease. The best-known examples are human papillomavirus (HPV), hepatitis B and hepatitis C, Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV, also called HHV-8), human T-cell leukemia virus type 1 (HTLV-1) and Merkel cell polyomavirus. Each is spread differently and is linked to different cancers: HPV to cervical, anal and throat cancers, hepatitis B and C to liver cancer, EBV to certain lymphomas and nose and throat cancers, KSHV to Kaposi sarcoma, HTLV-1 to adult T-cell leukemia/lymphoma, and Merkel cell polyomavirus to Merkel cell carcinoma (a rare skin cancer). These viruses can disrupt the signals that normally keep cell growth in check, or cause long-lasting inflammation that damages tissue over years. HIV (human immunodeficiency virus) works differently: it does not cause cancer directly, but by weakening the immune system it makes cancers driven by other viruses more likely. Infection is common and usually causes no symptoms, and most people infected with these viruses never develop cancer. What matters is which virus is involved, whether the infection persists and how well the immune system keeps it in check.
Most of these viruses pass from person to person through blood, sexual contact or saliva. HPV spreads easily through vaginal, anal and oral sex, and nearly all sexually active people who are not vaccinated are infected at some point. Hepatitis B and C spread mainly through blood, such as shared needles, and from mother to baby at birth; hepatitis B also spreads through sex. EBV spreads through saliva, and more than 90% of people worldwide carry it for life. Infection is the necessary first step, but other factors decide whether cancer follows. The most important is a weakened immune system, from HIV, an organ transplant or immune-suppressing medicines. Long-lasting infection matters too: an HPV infection that persists for many years, or hepatitis that goes untreated for decades, carries far more risk than a brief one. Where someone grew up also plays a part, because some of these viruses are much more common in certain regions. HTLV-1, for example, is more common in Japan, Africa, the Caribbean and South America than in the United States.
There is no single test for tumor virus infections, because each virus is found in its own way. Many people learn about an infection through routine screening rather than symptoms. Hepatitis B and C are detected with blood tests. The Centers for Disease Control and Prevention (CDC) recommends that every adult be tested at least once in their life for both, and that pregnant women be tested for hepatitis B and hepatitis C in each pregnancy, because these infections can damage the liver silently for decades. A positive result usually leads to further blood tests and a liver ultrasound to see whether the liver is affected. HPV in the cervix is found through cervical cancer screening, which uses a Pap test, an HPV test or both on a sample of cervical cells. An abnormal result may lead to a colposcopy, a closer look at the cervix with a magnifying instrument and sometimes a small tissue sample. HIV is diagnosed with a blood test, and HTLV-1 can be tested in people at risk. For EBV, KSHV and Merkel cell polyomavirus, which most people carry without harm, testing usually happens only when a related illness or cancer is being investigated, often by examining a tissue sample.
Care depends on the virus, and for several of them the most powerful tools are prevention and early detection rather than treatment of the infection itself. Vaccines prevent two of the most important infections. The HPV vaccine protects against the types that cause most HPV-related cancers and works best before a person is ever exposed, which is why it is recommended at age 11 or 12 (it can start at 9 and continue through 26). Adults over 26 who were not vaccinated can ask a clinician whether it would still help them. The hepatitis B vaccine is routinely given in infancy. It is also recommended for all unvaccinated adults up to age 59, whether or not they have a known risk, and for adults 60 and older who have risk factors (older adults without risk factors can also choose to get it). HPV infection itself has no treatment, and most infections clear on their own. What can be treated are the precancerous cell changes that a persistent infection can cause. Screening finds them, and removing them helps prevent cervical cancer from developing. Hepatitis C can be cured in most people with 8 to 12 weeks of antiviral pills, which removes the ongoing liver damage that leads to cancer. Chronic hepatitis B is usually controlled rather than cured: antiviral medicines suppress the virus when the liver needs protecting, and regular checkups watch for liver damage and early liver cancer. For HIV, daily antiretroviral treatment keeps the immune system strong, which lowers the risk of virus-related cancers such as Kaposi sarcoma. There is no vaccine or specific treatment for EBV, KSHV, HTLV-1 or Merkel cell polyomavirus. For these, care focuses on supporting immune health where possible and recognizing related illnesses early.
For most people, learning they carry one of these viruses does not mean cancer is likely. Many infections clear on their own or stay quiet for life, and the cancers they are linked to usually take years or decades to develop, which leaves time for screening and treatment to work. What follows depends on the virus. Someone cured of hepatitis C no longer has the infection, although people who already had liver scarring may still need regular liver checks. Someone with chronic hepatitis B typically has blood tests and liver checks on a schedule for life. A person with HPV-related cell changes may have repeat screening or a minor procedure, then return to routine screening. People with HIV, an organ transplant or other causes of weak immunity are usually followed more closely, because their risk of virus-related cancers is higher. Some of these viruses can be passed to partners, household members or babies. Knowing your status lets your clinician explain how to avoid passing the infection on.
Talk with a clinician about testing if you have never been tested for hepatitis B or C, if you have shared needles, had a sexual partner with one of these infections or have a weakened immune system, or if you are unsure whether you or your child are vaccinated against HPV and hepatitis B. Keep up with cervical screening and follow up on any abnormal result. Contact your care team if you notice yellowing of the skin or eyes or dark yellow urine, which can signal liver inflammation. If you already know you have one of these infections, ask how you will be monitored and which changes should bring you in sooner.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Tumor Virus Infections is like, what's helped you, or ask the community a question.